Literature DB >> 2177810

[Endogenous natriuretic and ouabain-like factors. Their potential role in volume and blood pressure regulation].

H J Kramer1, A Bäcker, G Krampitz, H Meyer-Lehnert, H Michel.   

Abstract

The existence of an endogenous natriuretic hormone and ouabain-like factors (OLF) has been postulated for many years. This postulate was based on our original observation that a small M.W. fraction in the serum after acute expansion of the extracellular fluid volume (ECFV) not only exhibited natriuretic activity but also inhibited the Na-K-ATPase enzyme in vitro similar to ouabain. Since then, numerous studies confirmed the presence of OLFs in serum, urine, cerebrospinal fluid, and various organs including the heart and hypothalamus. Some of these OLFs are well-known endogenous compounds, such as free unsaturated fatty acids, which inhibit in vitro transmembranous sodium transport, Na-K-ATPase and 3H-ouabain binding to its membrane receptor or cross-react with digoxin antibodies. Chemically yet undefined OLFs of potentially hypothalamic origin were detected in various models of experimental and clinical hypertension and are suggested to play a pathophysiological role especially in salt- and volume-dependent forms of hypertension. Our results show that OLFs isolated from the urine of salt-loaded healthy subjects strongly enhance basal and vasopressin-stimulated release of calcium in vascular smooth muscle cells and platelets similar to the effects we had observed with endothelin. This urine fraction also exhibits natriuretic activity which increases in parallel with sodium intake. Further chromatographic separation and amino acid analysis confirmed the peptidic nature (M.W. less than 1000) of the natriuretic factor(s). However, the two biological activities, namely natriuretic and ouabain-like activities, reside in distinct and chemically different compounds.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177810     DOI: 10.1007/BF01798061

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  40 in total

1.  Characteristics of an inhibitor of the Na+/K+ pump in human cerebrospinal fluid.

Authors:  J A Halperin; J F Riordan; D C Tosteson
Journal:  J Biol Chem       Date:  1988-01-15       Impact factor: 5.157

2.  Antinatriferic activity in human plasma following acute and chronic salt-loading.

Authors:  H J Kramer; A Bäcker; F Krück
Journal:  Kidney Int       Date:  1977-09       Impact factor: 10.612

3.  Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.

Authors:  H J Kramer; A Baecker; E Weiler; C Liddiard
Journal:  Klin Wochenschr       Date:  1986-08-15

4.  Endogenous digitalis-like substance in plasma of volume-expanded dogs.

Authors:  K A Gruber; J M Whitaker; V M Buckalew
Journal:  Nature       Date:  1980-10-23       Impact factor: 49.962

5.  Partial purification and properties of the inhibitors of Na, K-ATPase and ouabain-binding in bovine central nervous system.

Authors:  K Akagawa; N Hara; Y Tsukada
Journal:  J Neurochem       Date:  1984-03       Impact factor: 5.372

6.  Presence of digitalis-like factor in mammalian plasma.

Authors:  A Goto; K Yamada; M Ishii; M Yoshioka; T Ishiguro; C Eguchi; T Sugimoto
Journal:  Biochem Biophys Res Commun       Date:  1988-04-15       Impact factor: 3.575

7.  Extraction and characterization of a cytochemically assayable Na+/K+-ATPase inhibitor/glucose-6-phosphate dehydrogenase stimulator in the hypothalamus and plasma of man and the rat.

Authors:  J A Millett; S M Holland; J Alaghband-Zadeh; H E de Wardener
Journal:  J Endocrinol       Date:  1987-02       Impact factor: 4.286

8.  Identification of a ouabain-like compound in toad skin and plasma as a bufodienolide derivative.

Authors:  D Lichtstein; S Kachalsky; J Deutsch
Journal:  Life Sci       Date:  1986-04-07       Impact factor: 5.037

9.  Identification of NaK-ATPase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids.

Authors:  R A Kelly; D S O'Hara; W E Mitch; T W Smith
Journal:  J Biol Chem       Date:  1986-09-05       Impact factor: 5.157

10.  Digoxin-like immunoreacting substance(s) in the serum of patients with chronic uremia.

Authors:  H J Kramer; J Pennig; D Klingmüller; J Kipnowski; K Glänzer; R Düsing
Journal:  Nephron       Date:  1985       Impact factor: 2.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.